Posted On: Monday, December 5th, 2016
A redesign of PHSA-held community contracts was initiated in 2014 to better enable the BC Centre for Disease Control (BCCDC) and BC Women’s Hospital & Health Centre to respond to current trends in the HIV and HCV epidemics, and to better align the strategic direction with the Ministry of Health’s Hope To Health Framework, the… Read more »
Posted On: Tuesday, September 20th, 2016
In May 2016, the 194 member states of the World Health Organization (WHO), including Canada, adopted the first ever Global Viral Hepatitis Strategy with the goal of eliminating viral hepatitis by 2030. The elimination of HCV across Canada will require federal leadership. An effective national strategy would align and coordinate all of those involved in… Read more »
Posted On: Monday, September 12th, 2016
Hope you will enjoy HepCBC’s SUMMER, 2016 hepc.bull newsletter. This is our LAST NEWSLETTER to you in this format as we are transitioning to sending all of our news out via our website, Facebook site, and You Tube Channel. It’s been over 20 years, and we are so proud of what our bulletin has accomplished and the many lives it has touched,… Read more »
Posted On: Wednesday, September 7th, 2016
PAN has recently launched a new, online tool to support the building of shared, or common measures for community-based HIV and HCV Organizations in BC. This tool outlines a series of indicators that can be used to measure the contribution community-based HIV/HCV organizations are making to the prevention and care cascade in their region. It is hoped… Read more »
Posted On: Tuesday, August 23rd, 2016
The victims of Canada’s tainted blood scandal, those involved in the 1986-1990 Hepatitis C Settlement Agreement, have won their court case against the Attorney General of Canada. The settlement claimants will now share the $207 million remaining compensation fund surplus. Instead of being returned to the government, most of the remaining surplus will now go… Read more »
Posted On: Tuesday, August 16th, 2016
Wednesday August 24th, 2016 11a.m. EST [90 mins] Register now 35% of hepatitis C cases are among immigrants! Many more don’t know that they have it. The objective of this webinar is to create a better understanding of hepatitis C issues and challenges unique to immigrants and newcomers to Canada. The webinar is co-hosted by… Read more »
Posted On: Tuesday, August 9th, 2016
New and noteworthy CATIE News: Liver cancer rates low in people with HIV and hepatitis C People with HIV and hepatitis C coinfection have low rates of liver cancer (about 1%), reported researchers in Clinical Infectious Diseases. This study drew information from four databases of people coinfected with HIV and hepatitis C and included 7,229… Read more »
Posted On: Friday, August 5th, 2016
July 28th marked World Hepatitis Day. World Hepatitis Day is an international event focused on raising awareness about viral hepatitis and works to influence real change in disease prevention and access to testing and treatment. In Canada, there is an estimated 250,000 people living with chronic hepatitis C in Canada, many of them are unaware of their… Read more »
Posted On: Tuesday, August 2nd, 2016
CPHA will be hosting a series of webinars throughout fall 2016 and winter 2017 to increase understanding of the stigma associated with sexually transmitted and blood-borne infections (STBBIs) as well as sexuality and substance use. CPHA is inviting the public health community to submit webinar proposals focused on understanding and reducing STBBI-related stigma. Click here… Read more »
Posted On: Tuesday, August 2nd, 2016
The “Hepatitis C Treatment Options: Basic Information for Patients” is now available directly on the Hepatitis Education Canada website. The tool allows people to input information about their own: • Genotype • treatment history, and • cirrhosis status to display selected CASL & AASLD recommended treatments. Also included on site are videos to help people… Read more »
Posted On: Monday, July 25th, 2016
On July 11, 2016, Health Canada licensed the sale and use of a new fixed-dose combination of two anti-hepatitis C virus (HCV) drugs sold under the brand name Epclusa and made by the pharmaceutical company Gilead Sciences. Epclusa contains the following medicines: sofosbuvir – 400 mg velpatasvir – 100 mg Clinical trials In clinical trials,… Read more »
Posted On: Monday, July 18th, 2016
2016 World Hepatitis Day Events in British Columbia Collected by Pacific AIDS Network FRASER Sponsoring Agency: Stride with Purpose Program at the Lower Mainland Purpose Society When: Thursday, July 28 from 8:00am – 9:00am Where: Lougheed Skytrain Station Event Details: Stride with Purpose will be at the Lougheed Skytrain Station handing out treats and… Read more »
